al102
ayala pharmaceuticalsceuticals,novartis
['al102', 'gamma', 'ringside', 'ayala']
 on monday at #esmo2022, prof. , md, ( ) presented the data from ringside phase 2/3 clinical trial for al102 (a gamma-secretase inhibitor) in #desmoid tumor patients. press release: 
The Desmoid Tumor Research Foundation (DTRF) is the only 501(c)3 in the U.S. solely dedicated to finding a cure for desmoid tumors, a rare soft tissue sarcoma.